University of Chicago
Glucocorticoid receptor activation protects tumor cells via MAPK inhibition
Published in Health Insurance Week, May 1st, 2005
GR activation "has recently been shown to inhibit apoptosis in breast epithelial cells," according to scientists in the United States, who "previously described a group of genes that is rapidly upregulated in these cells following dexamethasone (Dex) treatment."
In their subsequent study, conducted "to dissect the mechanisms of GR-mediated breast epithelial cell survival," W. Wu and coauthors at the University of Chicago examined "the molecular events downstream of GR activation."
GR activation "leads to both the rapid induction of MAPK...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Assurant, Inc.
William D. Greiter named senior VP, corporate development, by insurance company - Gordian Health Solutions, Inc.
Insurer applauds Medicare decision to begin covering cost of tobacco cessation - Health Promotion
Colorado health plan members get chiropractic, fitness affinity program - Univ. of California, San Diego
More than one in four workers will be uninsured in 2013 - Advanced Neuromodulation Systems
U.S. FDA grants IDE approval to investigate device for essential tremor - Albert Einstein College of Medicine, Bronx
Nutrient-dependent responses to visceral and subcutaneous fat depots studied - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
